Occurrence rate and genotype distribution of the JC virus (JCV) in a sample from the Polish population
Corresponding Author
Dariusz Kmieciak
Department of Biochemistry and Molecular Biology, Karol Marcinkowski University of Medical Sciences, Poznan, Poland
Department of Biochemistry and Molecular Biology, Karol Marcinkowski University of Medical Sciences, 6 Swiecickiego St., 60-781 Poznan, Poland.===Search for more papers by this authorSzymon Dębicki
Department of Biochemistry and Molecular Biology, Karol Marcinkowski University of Medical Sciences, Poznan, Poland
Search for more papers by this authorWiesław H. Trzeciak
Department of Biochemistry and Molecular Biology, Karol Marcinkowski University of Medical Sciences, Poznan, Poland
Search for more papers by this authorCorresponding Author
Dariusz Kmieciak
Department of Biochemistry and Molecular Biology, Karol Marcinkowski University of Medical Sciences, Poznan, Poland
Department of Biochemistry and Molecular Biology, Karol Marcinkowski University of Medical Sciences, 6 Swiecickiego St., 60-781 Poznan, Poland.===Search for more papers by this authorSzymon Dębicki
Department of Biochemistry and Molecular Biology, Karol Marcinkowski University of Medical Sciences, Poznan, Poland
Search for more papers by this authorWiesław H. Trzeciak
Department of Biochemistry and Molecular Biology, Karol Marcinkowski University of Medical Sciences, Poznan, Poland
Search for more papers by this authorAbstract
The JC virus (JCV) is a common human virus persisting in renal tissue. In immunocompromised individuals it may reactivate and cause progressive multifocal leukoencephalopathy (PML). JCV has also been implicated in cancerogenesis, leading to various brain tumors and cancers of gastrointestinal tract. In this study the JCV excretion in urine of 113 healthy Polish donors was analyzed. A 215-bp region of the viral gene coding for a major capsid protein VP1 was PCR-amplified and detected in 52 individuals (46.0%). The occurrence rate increased with age and was highest in the group of over 60-year-old donors (63.6%). Sequence analysis of the VP1 gene fragment revealed the following distribution of JCV genotypes in the investigated group: 1A, 31 (59.6%); 1B, 13 (25.0%); 2A, 2 (3.8%); and 2C, 6 samples (11.5%). The frequency and distribution of the JCV genotypes in the Polish population resembles that in other European countries, with the most abundant genotype 1 (84.6%). However, while in those countries the second most frequent genotype was usually 4, in the investigated group genotype 4 was not detected. J. Med. Virol. 80:1079–1083, 2008. © 2008 Wiley-Liss, Inc.
REFERENCES
- Agostini HT, Ryschkewitsch CF, Stoner GL. 1996. Genotype profile of human polyomavirus JC excreted in urine of immunocompetent individuals. J Clin Microbiol 34: 159–164.
- Agostini HT, Yanagihara R, Davis V, Ryschkewitsch CF, Stoner GL. 1997. Asian genotypes of JC virus in native Americans and in a Pacific Island population: Markers of viral evolution and human migration. Proc Natl Acad Sci USA 94: 14542–14546.
- Agostini HT, Deckhut A, Jobes DV, Girones R, Schlunck G, Prost MG, Frias C, Peres-Trallero E, Ryschkewitsch CF, Stoner GL. 2001. Genotypes of JC virus in East, Central and Southwest Europe. J Gen Virol 82: 1221–1231.
- Ariza A, Mate JL, Fernandez-Vasalo A, Gomez-Plaza C, Perez-Piteira J, Pujol M, Navas-Palacios JJ. 1994. p53 and proliferating cell nuclear antigen expression in JC virus-infected cells of progressive multifocal leukoencephalopathy. Hum Pathol 25: 1341–1345.
- Berger JR, Miller CS, Mootoor Y, Avdiushko SA, Kryscio RJ, Zhu H. 2006. JC virus detection in bodily fluids: Clues to transmission. Clin Infect Dis 43: e9–e12.
- Caracciolo V, Reiss K, Khalili K, De Falco G, Giordano A. 2006. Role of the interaction between large T antigen and Rb family members in the oncogenicity of JC virus. Oncogene 25: 5294–5301.
- Casini B, Borgese L, Del Nonno F, Galati G, Izzo L, Caputo M, Perrone-Donnorso R, Castelli M, Risuleo G, Visca P. 2005. Presence and incidence of DNA sequences of human polyomaviruses BKV and JCV in colorectal tumor tissues. Anticancer Res 25: 1079–1085.
- Chang H, Wang M, Tsai RT, Lin HS, Huan JS, Wang WC, Chang D. 2002. High incidence of JC viruria in JC-seropositive older individuals. J Neurovirol 8: 447–451.
- Cui X, Wang JC, Deckhut A, Joseph BC, Eberwein P, Cubitt CL, Ryschkewitsch CF, Agostini HT, Stoner GL. 2004. Chinese strains (Type 7) of JC virus are afro-asiatic in origin but are phylogenetically distinct from the Mongolian and Indian strains (Type 2D) and the Korean and Japanese strains (Type 2A). J Mol Evol 58: 568–583.
- Del Valle L, Gordon J, Assimakopoulou M, Enam S, Geddes JF, Varakis JN, Katsetos CD, Croul S, Khalili K. 2001. Detection of JC virus DNA sequences and expression of the viral regulatory protein T-antigen in tumors of the central nervous system. Cancer Res 61: 4287–4293.
- Del Valle L, White MK, Enam S, Oviedo SP, Bromer MQ, Thomas RM, Parkman HP, Khalili K. 2005. Detection of JC virus DNA sequences and expression of viral T antigen and agnoprotein in esophageal carcinoma. Cancer 103: 516–527.
- Dubois V, Moret H, Lafon M-E, Brodard V, Icart J, Ruffault A, Guist'hau O, Buffet-Janvresse C, Abbed K, Dussaix E, Ingrand D. 2001. JC virus genotypes in France: Molecular epidemiology and potential significance for progressive multifocal leukoencephalopathy. J Infect Dis 183: 213–217.
- Eash S, Manley K, Gasparovic M, Querbes W, Atwood WJ. 2006. The human polyomaviruses. Cell Mol Life Sci 63: 865–876.
- Frisque RJ, Bream GL, Cannella MT. 1984. Human polyomavirus JC virus genome. J Virol 51: 458–469.
- Frisque RJ, Hofstetter C, Tyagarajan SK. 2006. Transforming activities of JC virus early proteins. Adv Exp Med Biol 577: 288–309.
- Guo J, Kitamura T, Ebihara H, Sugimoto C, Kunitake T, Takehisa J, Na YQ, Al-Ahdal MN, Hallin A, Kawabe K, Taguchi F, Yogo Y. 1996. Geographical distribution of the human polyomavirus JC virus type A and B and isolation of a new type from Ghana. J Gen Virol 77: 919–927.
- Hatwell JN, Sharp PM. 2000. Evolution of human polyomavirus JC. J Gen Virol 81: 1191–1200.
- Ikegaya H, Zheng HY, Saukko PJ, Varesmaa-Korhonen L, Hovi T, Vesikari T, Suganami H, Takasaka T, Sugimoto C, Ohasi Y, Kitamura T, Yogo Y. 2005. Genetic diversity of JC virus in the Saami and the Finns: Implications for their population history. Am J Phys Anthropol 128: 185–193.
- Jeong BH, Lee KH, Choi EK, Kim K, Kim YS. 2004. Genotyping of the JC virus in urine samples of healthy Korean individuals. J Med Virol 72: 281–289.
- Jobe DV, Friedlaender JS, Mgone CS, Agostini HT, Koki G, Yanagihara R, Ng TCN, Chima SC, Ryschkewitsch CF, Stoner GL. 2001. New JC virus (JCV) genotypes from Papua New Guinea and Micronesia (type 8 and type 2E) and evolutionary analysis of 32 complete JCV genomes. Arch Virol 146: 2097–2113.
- Jobes DV, Chima SC, Ryschkewitsch CF, Stoner GL. 1998. Phylogenetic analysis of 22 complete genomes of the human polyomavirus JC vitus. J Gen Virol 79: 2491–2498.
- Khalili K, Gordon J, White MK. 2006. The polyomavirus, JCV and its involvement in human disease. Adv Exp Med Biol 577: 274–287.
-
Krynska B,
Gordon J,
Otte J,
Franks R,
Knobler R,
DeLuca A,
Giordano A,
Khalili K.
1997.
Role of cell cycle regulators in tumor formation in transgenic mice expressing the human neurotropic virus, JCV, early protein.
J Cell Biochem
67:
223–230.
10.1002/(SICI)1097-4644(19971101)67:2<223::AID-JCB7>3.0.CO;2-Z CAS PubMed Web of Science® Google Scholar
- Krynska B, Otte J, Franks R, Khalili K, Croul S. 1999. Human ubiquitous JCV(CY) T-antigen gene induces brain tumors in experimental animals. Oncogene 18: 39–46.
- Major EO, Amemiya K, Tornatore CS, Houff SA, Berger JR. 1992. Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 5: 49–73.
- Murai Y, Zheng HC, Aziz HO, Mei H, Kutsuna T, Nakanishi Y, Tsuneyama K, Takano Y. 2007. High JC virus load in gastric cancer and adjacent non-cancerous mucosa. Cancer Sci 98: 25–31.
- Pagani E, Delbue S, Mancuso R, Borghi E, Tarantini L, Ferrante P. 2003. Molecular analysis of JC virus genotypes circulating among the Italian healthy population. J Neurovirol 9: 559–566.
- Ricciardiello L, Baglioni M, Giovannini C, Pariali M, Cenacchi G, Ripalti A, Landini MP, Sawa H, Nagashima K, Frisque RJ, Goel A, Boland CR, Tognon M, Roda E, Bazzoli F. 2003. Induction of chromosomal instability in colonic cells by the human polyomavirus JC virus. Cancer Res 63: 7256–7262.
- Schaffer K, Sheehy N, Coughlan S, Bergin C, Hall WW. 2006. JC virus in the Irish population: Significant increase of genotype 2 in immunocomromised individuals. J Neurovirol 12: 39–46.
- Sugimoto C, Kitamura T, Guo J, Al-Ahdal MN, Shchelkunov SN, Otova B, Ondrejka P, Chollet J-Y, El-Safi S, Ettayebi M, Grésenguet G, Kocagöz T, Chaiyarasamee S, Thant KZ, Thein S, Moe K, Kobayashi N, Taguchi F, Yogo Y. 1997. Typing of urinary JC virus DNA offers a novel means of tracing human migrations. Proc Natl Acad Sci USA 94: 9191–9196.
- White MK, Khalili K. 2006. Interaction of retinoblastoma protein family members with large T-antigen of primate polyomaviruses. Oncogene 25: 5286–5293.
- White MK, Gordon J, Reiss K, Del Valle L, Croul S, Giordano A, Darbinyan A, Khalili K. 2005. Human polyomaviruses and brain tumors. Brain Res Brain Res Rev 50: 69–85.